Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Certain drugs can cause hair loss, but stopping the drug usually leads to hair regrowth.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Infliximab can trigger lupus-like symptoms in Crohn's disease patients.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Various treatments can help manage hidradenitis suppurativa based on its severity.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

Etanercept is safe and may help improve hidradenitis suppurativa, but more research is needed.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Different races and genders have unique skin and hair issues, requiring specialized care and more research for effective treatment.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

Nutrafol might help reduce hair loss due to inflammation, but more evidence is needed.

Finasteride may cause depression and affect brain and gut health in male rats.

Certain cytokines and growth factors can inhibit hair growth and may affect alopecia areata.